GLOW LIFETECH CORP. (9DO) - Total Assets
Based on the latest financial reports, GLOW LIFETECH CORP. (9DO) holds total assets worth €3.70 Million EUR (≈ $4.32 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 9DO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
GLOW LIFETECH CORP. - Total Assets Trend (2021–2024)
This chart illustrates how GLOW LIFETECH CORP.'s total assets have evolved over time, based on quarterly financial data. See 9DO total equity for net asset value and shareholders' equity analysis.
GLOW LIFETECH CORP. - Asset Composition Analysis
Current Asset Composition (December 2024)
GLOW LIFETECH CORP.'s total assets of €3.70 Million consist of 70.4% current assets and 29.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 34.7% |
| Accounts Receivable | €409.83K | 11.0% |
| Inventory | €266.44K | 7.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €670.33K | 18.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how GLOW LIFETECH CORP.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 9DO company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GLOW LIFETECH CORP.'s current assets represent 70.4% of total assets in 2024, an increase from 34.3% in 2021.
- Cash Position: Cash and equivalents constituted 34.7% of total assets in 2024, up from 19.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 18.0% of total assets.
GLOW LIFETECH CORP. Competitors by Total Assets
Key competitors of GLOW LIFETECH CORP. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
ALTEOGEN Inc
KQ:196170
|
Korea | ₩729.47 Billion |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
|
USA | $1.29 Billion |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX
|
USA | $440.10 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Galapagos N.V.
AS:GLPG
|
Netherlands | €3.37 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
GLOW LIFETECH CORP. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.16 | 0.62 | 0.62 |
| Quick Ratio | 1.89 | 0.55 | 0.55 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.40 Million | €-861.92K | €-861.92K |
GLOW LIFETECH CORP. - Advanced Valuation Insights
This section examines the relationship between GLOW LIFETECH CORP.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.55 |
| Latest Market Cap to Assets Ratio | 0.97 |
| Asset Growth Rate (YoY) | 175.4% |
| Total Assets | €3.72 Million |
| Market Capitalization | $3.60 Million USD |
Valuation Analysis
Near Book Valuation: The market values GLOW LIFETECH CORP.'s assets close to their book value (0.97x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: GLOW LIFETECH CORP.'s assets grew by 175.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for GLOW LIFETECH CORP. (2021–2024)
The table below shows the annual total assets of GLOW LIFETECH CORP. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €3.72 Million ≈ $4.35 Million |
+175.43% |
| 2023-12-31 | €1.35 Million ≈ $1.58 Million |
-43.23% |
| 2022-12-31 | €2.38 Million ≈ $2.78 Million |
-36.77% |
| 2021-12-31 | €3.76 Million ≈ $4.40 Million |
-- |
About GLOW LIFETECH CORP.
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products, as well as precision-dosed capsules. It has exclusive North American rights for the production,… Read more